FDA BACPAC -1 Draft Guidance Uses Decision-Tree Approach
This article was originally published in The Tan Sheet
Executive Summary
FDA's Bulk Active Post-Approval Changes draft guidance (BACPAC -1) incorporates a decision-tree approach in which the determination of the filing and testing requirements rests on an evaluation process rather than fixed standards used in FDA's Scale-Up & Post-Approval Changes (SUPAC) guidance.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning